pfizer glp 1 Pfizer's Push into GLP‑1 Drugs Signals a New Era in Obesity Treatment — and a Danuglipron: An Oral GLP-1R Agonist

One is that GLP-1 medications slow down the movement of your GI tract

10.2337/dc10-0187 [DOI] [PMC free article] [PubMed] [Google Scholar] 200.Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, et al

These findings reinforce the notion that metabolic dysfunction, and obesity in particular, is not merely a comorbidity but an active modifier of PsA pathophysiology and treatment outcomes

Higher doses increase side effects

However, a small sample found that Lira did not significantly change levels of the hepatic fat oxidation marker -hydroxybutyrate, although it reduced liver fat [68]

First, lets talk about specific foods that stimulate GLP-1 production in the body